Lung cancer is the leading cause of cancer death worldwide. Early detection is critical to effective treatment. The Alaoui Lab, a core research lab in the Thoracic Oncology Program, is focused on elucidating diagnostic biomarkers and developing novel targeted therapies for treatment of lung cancer, mesothelioma and esophageal cancer. We seek to gain a keen understanding of the molecular mechanisms underlying these diseases. Our projects include:
Our lab employs state-of-the-art molecular and cellular technologies including the Affy-gene Titan high throughput expression analysis and ABI HT 7900 qPCR, and has access to the Thoracic Oncology Tissue Bank, one of the largest repositories of lung tumor tissue specimens in the world.